Skip to content
Disclosery

Camber Capital Management LP: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Camber Capital Management LP on GSK, newest first. How the timeline and the estimate are built.

Camber Capital Management LP held 0 GSK shares at 2025-03-31 per its 13F-HR filed 2025-05-15.

the latest 13F is the newest step

  1. period ended2025-03-31
    13F 0 shares
    Change vs previous 13F -2,500,000 shares

    13F-HR 0001654954-25-005756 filed by Camber Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2024-12-31
    13F 2,500,000 shares
    Change vs previous 13F -500,000 shares

    3.31% of the 13F portfolio, value $84,550,000.

    13F-HR 0001654954-25-001508 filed by Camber Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-09-30
    13F 3,000,000 shares
    Change vs previous 13F +325,000 shares

    4.76% of the 13F portfolio, value $122,640,000.

    13F-HR 0001654954-24-014364 filed by Camber Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-06-30
    13F 2,675,000 shares
    Change vs previous 13F +500,000 shares

    3.97% of the 13F portfolio, value $102,988,000.

    13F-HR 0001654954-24-010537 filed by Camber Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-03-31
    13F 2,175,000 shares
    Change vs previous 13F 0 shares

    3.26% of the 13F portfolio, value $93,242,000.

    13F-HR 0001654954-24-006308 filed by Camber Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2023-12-31
    13F 2,175,000 shares
    Change vs previous 13F -675,000 shares

    2.82% of the 13F portfolio, value $80,606,000.

    13F-HR 0001654954-24-001698 filed by Camber Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2023-09-30
    13F 2,850,000 shares
    Change vs previous 13F not available

    3.71% of the 13F portfolio, value $103,313,000.

    13F-HR 0001654954-23-014248 filed by Camber Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).